Mitsui et al. [42] reported the effects of the treatment with CoQ10 1200 mg/day in a patient diagnosed with familial MSA, in an advanced stage, related to the compound heterozygous nonsense (R387X) and missense (V393A) mutations in the COQ2 gene. The gene discussed is COQ2; the disease is multiple system atrophy.